Gary Patou
Director, Genome Therapeutics Corporation.
Companies
- Xenon PharmaceuticalsBoard member Nov 4, 2014 to now1
- Pacira BioSciences, Inc.Chief Medical Officer Feb 2, 2011 to Aug 8, 20142
- Pacira BioSciences, Inc.Board member Jun 7, 2012 to Jun 7, 20123
- Genome Therapeutics CorporationBoard member Jan 4, 2006 to Jun 13, 20084
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Xenon Pharmaceuticals XENE29,798 shares5$1.0M at $34.78Jun 8, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 5, 2026Sold 1,322 shares at $53.14 of Xenon Pharmaceuticals5
- Jun 1, 2026Exercised options 2,645 shares of Xenon Pharmaceuticals6
- Nov 22, 2024Sold 2,040 shares at $41.05 of Xenon Pharmaceuticals7
- Nov 22, 2024Shares withheld for tax 1,046 shares at $39.80 of Xenon Pharmaceuticals7
- Nov 22, 2024Exercised options 3,086 shares at $13.48 of Xenon Pharmaceuticals7
- Nov 22, 2024Sold 2,851 shares at $41.11 of Xenon Pharmaceuticals7
- Nov 22, 2024Shares withheld for tax 649 shares at $39.80 of Xenon Pharmaceuticals7
- Nov 22, 2024Exercised options 3,500 shares at $7.38 of Xenon Pharmaceuticals7
- Dec 14, 2023Sold 7,598 shares at $41.05 of Xenon Pharmaceuticals8
- Dec 13, 2023Sold 7,598 shares at $41.05 of Xenon Pharmaceuticals9
- Dec 13, 2023Sold 3,977 shares at $39.84 of Xenon Pharmaceuticals9
- Dec 13, 2023Shares withheld for tax 1,167 shares at $39.68 of Xenon Pharmaceuticals9
- Dec 13, 2023Exercised options 5,144 shares at $9.00 of Xenon Pharmaceuticals9
- Dec 13, 2023Sold 2,303 shares at $39.10 of Xenon Pharmaceuticals9
- Dec 13, 2023Shares withheld for tax 577 shares at $39.68 of Xenon Pharmaceuticals9
- Dec 13, 2023Exercised options 2,880 shares at $9.85 of Xenon Pharmaceuticals9
- Dec 13, 2023Sold 5,100 shares at $38.94 of Xenon Pharmaceuticals9
- Dec 13, 2023Shares withheld for tax 1,278 shares at $39.68 of Xenon Pharmaceuticals9
- Dec 13, 2023Exercised options 6,378 shares at $9.85 of Xenon Pharmaceuticals9
- Nov 25, 2022Sold 1,937 shares at $34.79 of Xenon Pharmaceuticals10
- Nov 25, 2022Shares withheld for tax 120 shares at $34.37 of Xenon Pharmaceuticals10
- Nov 25, 2022Exercised options 2,057 shares at $2.68 of Xenon Pharmaceuticals10
- Nov 23, 2022Sold 2,057 shares at $34.33 of Xenon Pharmaceuticals10
- Dec 8, 2021Exercised options 2,057 shares at $3.67 of Xenon Pharmaceuticals11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARXenon Pharmaceuticals, Board member
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jun 3, 2026
- 7SEC EDGARForm 4 filed Nov 22, 2024
- 8SEC EDGARForm 4 filed Dec 15, 2023
- 9SEC EDGARForm 4 filed Dec 15, 2023
- 10SEC EDGARForm 4 filed Nov 28, 2022
- 11SEC EDGARForm 4 filed Dec 10, 2021